This report quantifies the patient potential in different cancer sub-markets and provides benchmarks for new cancer drug development and marketing strategies; identifying key areas of unmet need and profiling the market leading products of the future. The global cancer market is characterized by a mix of established gold standard therapies and new innovative products rapidly capturing market share. While a number of blockbuster therapies lose patent protection, heavy R&D investment has resulted in 400 potential new drugs currently progressing through clinical trials. Significant unmet needs and high incidence of disease continue to drive market growth, leaving a number of companies competing to improve treatment efficacy and drive market share. Use this report to quantify patient potential in cancer sub-markets, benchmark your portfolio against the eight leading companies in the sector and devise strategies to counter threats to your market position in the next five years.
ISBN 1-84296-416-X
Published: September 2004 - Global. |
